Ewan Townsend, Co-chair of Arnold & Porter’s Sustainability Committee, discusses the pharmaceutical sector’s shift towards environmentally friendly green chemistry.
Analysis of over 430,000 adults in the United States has unveiled concerning connections between cannabis consumption and heightened risks of heart attack and stroke.
A staggering 51.6 million Americans live with pain daily; Ellen Smith from the U.S. Pain Foundation tells us about how medical cannabis supports her management of chronic pain.
Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.
Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.
Over the past seven years, CBD wellness company Savage Cabbage has grown from a small family-run business into a globally recognised, high-quality brand, trusted as an authoritative voice, even in the corridors of Westminster.
In a concerted effort to combat the alarming issue of fatal drug deaths across the UK, the government has allocated £5 million to support 12 groundbreaking projects.
Poor adherence to drug therapies can lead to medication waste and poor patient outcomes. Tim Wooller shares some of the reasons behind poor adherence to medication and how connected drug delivery devices can help.
With a particular focus on South Korea, Open Access Government explores the changing perceptions around animal welfare and some of the policies introduced to support this.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how tackling wasted medicines is crucial to achieving sustainable healthcare.
